Orilissa 150 MG tablet 7S
Ended Awarded Last action
- Contract number
- SPE2DR26FW3ZN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,175
Award facts
- Contract value 100% obligated
- $11,174.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,174.92 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Orilissa 150 mg tablets (quantity 7s) on December 22, 2025, with an ultimate completion date of December 23, 2025. This non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle that runs through December 2026 and enables the company to deliver a broad range of medications and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant federal contracting presence with the Defense Logistics Agency's Medical Supply Chain. The company has demonstrated capability to compete successfully for federal medical procurement across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This particular delivery order for Orilissa, an endometriosis treatment medication, reflects the company's role in supplying specialized pharmaceuticals to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The award was made through open competition without set-aside restrictions, underscoring AmerisourceBergen's competitive standing as a preferred pharmaceutical vendor for federal military and veteran healthcare procurement.
Quick answers
Who was awarded contract SPE2DR26FW3ZN?
SPE2DR26FW3ZN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FW3ZN worth?
The government has obligated $11,175 on SPE2DR26FW3ZN.
Is contract SPE2DR26FW3ZN an order under another contract?
Yes. SPE2DR26FW3ZN is a delivery order under SPE2DR25D7067, an indefinite delivery contract.
Was contract SPE2DR26FW3ZN competed?
The extent of competition for SPE2DR26FW3ZN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award